US equities
|
NVDA
$152.03
▼-2.21%
MU
$702.17
▼-1.44%
AMD
$514.49
▲+2.20%
SPCX
$144.38
▲+1.89%
SNDK
$776.81
▼-2.56%
TSLA
$384.13
▲+1.06%
AAPL
$353.44
▲+0.43%
AMZN
$266.21
▲+3.23%
NVDA
$152.03
▼-2.21%
MU
$702.17
▼-1.44%
AMD
$514.49
▲+2.20%
SPCX
$144.38
▲+1.89%
SNDK
$776.81
▼-2.56%
TSLA
$384.13
▲+1.06%
AAPL
$353.44
▲+0.43%
AMZN
$266.21
▲+3.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Psyence Biomedical Ltd. - Common Shares
(NQ:
PBM
)
2.360
-0.150 (-5.98%)
Delayed Quote
Updated: 12:42 PM EST, Nov 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Psyence Biomedical Ltd. - Common Shares
Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research
April 20, 2026
Via
AB Newswire
Loop Industries (NASDAQ: LOOP) Ignites Paradigm Shift – Twist™ A Breakthrough in Circular Sustainability – More Stocks Inside
August 04, 2025
Via
AB Newswire
Topics
Economy
Loop Industries (Nasdaq: LOOP) Unveils Game-Changing Twist™ Polyester Made Entirely from Textile Waste – More Stocks Inside
July 31, 2025
Via
AB Newswire
Topics
Economy
Emissions
Energy
PsychedelicNewsBreaks – Psyence Biomedical Ltd. (NASDAQ: PBM) to Present at Psychedelic Science 2025
June 18, 2025
Via
Investor Brand Network
Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein
March 18, 2025
New York, New York--(Newsfile Corp. - March 18, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence Biomed" or the "Company")...
Via
Newsfile
“Power Nickel (TSX.V: PNPN) (OTCQB: PNPNF) Announces Dividend – MIGI, PRFX, PBM, CSDX Stocks Trending Now!”
December 05, 2024
Via
AB Newswire